High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms

International Journal of Pharmaceutics

Volumn 195, Issue 1-2, 2000, Pages 229-238

  Maggi, L ^a   Bruni, R ^a   Conte, U ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Controlled release; Hydrophilic matrix; Hydroxypropylmethylcellulose; Polyethylene oxides; Three layer system

Indexed keywords

DILTIAZEM; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; POLYMER;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DOSAGE FORM; MOLECULAR WEIGHT; PHARMACEUTICAL ENGINEERING; PRIORITY JOURNAL; TABLET FORMULATION; VISCOSITY;

CALCIUM CHANNEL BLOCKERS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DILTIAZEM; EXCIPIENTS; LACTOSE; METHYLCELLULOSE; MOLECULAR WEIGHT; OXAZINES; POLYETHYLENE GLYCOLS; TABLETS;

EID: 0033952741     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00402-0     Document Type: Article

References (14)

1. Alderman D.A. A review of cellulose ethers in hydrophilic matrices for oral controlled release dosage forms. Int. J. Pharm. 5:1984;1-9.
2. Apicella A., Cappello B., Del Nobile M.A., La Rotonda M.I., Mensitieri G., Nicholais L. Poly (ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release. Biomaterials. 14(2):1993;83-90.
3. Colorcon bulletin, 1992.
4. Conte U., Maggi L. Modulation of the dissolution profiles from Geomatrix® multi-layer matrix tablets containing drugs of different solubility. Biomaterials. 17:1996;889-896.
5. Conte U., Maggi L. Multi-layer tablets as drug delivery devices: Geomatrix® technology. Pharm. Tech. Europe. 1(2):1998;18-25.
6. Conte U., Maggi L., Colombo P., La Manna A. Multilayered hydrophilic matrices as constant release devices (Geomatrix™ Systems). J. Control. Release. 26:1993;39-47.
7. Conte U., Maggi L., La Manna A. Compressed barrier layers for constant drug release from swellable matrix tablets. Stp Pharma Sci. 4:1994;107-113.
8. Kim C.J. Drug release from compressed hydrophilic Polyox® WSR tablets. J. Pharm. Sci. 84(3):1995;303-306.
9. Kim C.J. Effects of drug solubility, drug loading and polymer molecular weight on drug release from Polyox® tablets. Drug Dev. Ind. Pharm. 24(7):1998;645-651.
10. Korsmeyer R.W., Peppas N.A. Swelling-controlled delivery systems for pharmaceutical applications: macromolecular and modelling considerations. Mansdorf S.Z., Roseman T.J. Controlled Release Delivery Systems. 1983;77-90 Marcel Dekker, New York.
11. Peppas N.A., Sahlin J.J. A simple equation for description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 57:1989;169-172.
12. Ritger P.L., Peppas N.A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release. 5:1987;37-42.
13. Royce, A.E., 1993. Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms. US Patent 5,273,758, 28 December.
14. Union Carbide bulletin, 1993.